Nano-X Imaging (NNOX) Competitors $5.89 +0.20 (+3.51%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends NNOX vs. AORT, ESTA, PLSE, BLFS, BVS, CBLL, EYE, FNA, LQDA, and AVNSShould you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Artivion (AORT), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Bioventus (BVS), CeriBell (CBLL), National Vision (EYE), Paragon 28 (FNA), Liquidia (LQDA), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. Nano-X Imaging vs. Artivion Establishment Labs Pulse Biosciences BioLife Solutions Bioventus CeriBell National Vision Paragon 28 Liquidia Avanos Medical Nano-X Imaging (NASDAQ:NNOX) and Artivion (NYSE:AORT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Which has preferable earnings & valuation, NNOX or AORT? Artivion has higher revenue and earnings than Nano-X Imaging. Artivion is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNano-X Imaging$9.90M34.38-$60.78M-$0.99-5.95Artivion$384.90M2.96-$30.69M-$0.02-1,358.00 Do institutionals and insiders hold more shares of NNOX or AORT? 21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 86.4% of Artivion shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 8.1% of Artivion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor NNOX or AORT? In the previous week, Nano-X Imaging had 1 more articles in the media than Artivion. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for Artivion. Artivion's average media sentiment score of 1.76 beat Nano-X Imaging's score of 0.35 indicating that Artivion is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Artivion 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Does the MarketBeat Community prefer NNOX or AORT? Nano-X Imaging received 5 more outperform votes than Artivion when rated by MarketBeat users. However, 78.57% of users gave Artivion an outperform vote while only 69.23% of users gave Nano-X Imaging an outperform vote. CompanyUnderperformOutperformNano-X ImagingOutperform Votes2769.23% Underperform Votes1230.77% ArtivionOutperform Votes2278.57% Underperform Votes621.43% Do analysts prefer NNOX or AORT? Nano-X Imaging presently has a consensus target price of $14.00, suggesting a potential upside of 137.69%. Artivion has a consensus target price of $31.00, suggesting a potential upside of 14.14%. Given Nano-X Imaging's higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Artivion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NNOX or AORT more profitable? Artivion has a net margin of -0.22% compared to Nano-X Imaging's net margin of -567.41%. Artivion's return on equity of 5.15% beat Nano-X Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Nano-X Imaging-567.41% -30.34% -26.99% Artivion -0.22%5.15%1.91% Which has more volatility and risk, NNOX or AORT? Nano-X Imaging has a beta of 2.01, indicating that its share price is 101% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. SummaryArtivion beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Nano-X Imaging News Delivered to You Automatically Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNOX vs. The Competition Export to ExcelMetricNano-X ImagingX IndustryBusiness SectorNASDAQ ExchangeMarket Cap$328.76M$31.06B$6.90B$8.81BDividend YieldN/A1.85%2.90%4.06%P/E Ratio-5.9511.3645.9017.77Price / Sales34.381.58171.6575.18Price / CashN/A12.2124.0532.53Price / Book1.663.535.044.68Net Income-$60.78M$532.37M$121.42M$226.08M7 Day Performance-2.32%-1.39%0.13%-1.04%1 Month Performance-2.00%-14.31%8.32%1.04%1 Year Performance-4.38%17.94%30.38%26.28% Nano-X Imaging Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNOXNano-X Imaging1.7317 of 5 stars$5.89+3.5%$14.00+137.7%-10.5%$328.76M$9.90M-5.95190AORTArtivion1.9659 of 5 stars$27.16+0.9%$31.00+14.1%+92.4%$1.14B$384.90M-1,358.001,500Positive NewsESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M0.00960High Trading VolumePLSEPulse Biosciences1.5329 of 5 stars$16.14-5.3%N/A+157.8%$1.05B$700,000.000.00140Positive NewsBLFSBioLife Solutions0.8729 of 5 stars$25.01+11.5%$27.50+10.0%+86.5%$1.04B$146.96M-23.59409Analyst ForecastInsider TradeAnalyst RevisionHigh Trading VolumeBVSBioventus2.7241 of 5 stars$11.41-1.6%$13.00+13.9%+195.6%$925.98M$555.06M-18.701,200Positive NewsCBLLCeriBellN/A$25.06-2.0%$31.20+24.5%N/A$897.65MN/A0.00N/AQuiet Period ExpirationAnalyst RevisionEYENational Vision3.0614 of 5 stars$11.34+0.5%$14.00+23.5%-42.1%$888.30M$2.13B0.0013,998Positive NewsFNAParagon 282.1549 of 5 stars$10.35-1.4%$15.60+50.7%-0.3%$879.06M$216.39M0.00343,000Analyst RevisionLQDALiquidia3.7407 of 5 stars$10.12-0.4%$24.00+137.2%+55.7%$859.91M$17.49M0.0050Analyst RevisionAVNSAvanos Medical3.9807 of 5 stars$17.87+0.4%N/A-16.6%$818.03M$673.30M52.563,771Positive News Related Companies and Tools Related Companies Artivion Competitors Establishment Labs Competitors Pulse Biosciences Competitors BioLife Solutions Competitors Bioventus Competitors CeriBell Competitors National Vision Competitors Paragon 28 Competitors Liquidia Competitors Avanos Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NNOX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nano-X Imaging Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nano-X Imaging With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.